282 filings
Page 2 of 15
8-K
dje3llb5t4zz7u9ne
5 May 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
p4y4n ums
28 Apr 22
Gilead Sciences Announces First Quarter 2022 Financial Results
4:07pm
8-K
fu808mr
7 Mar 22
Regulation FD Disclosure
8:30am
8-K
1gi1k
1 Feb 22
Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
4:07pm
8-K
2zp27tqn xchpbz5bblh
1 Feb 22
Results of Operations and Financial Condition
4:03pm
8-K
ip95 5kyoy1
6 Jan 22
Departure of Directors or Certain Officers
4:30pm
8-K
8is9 ayl782dmxjos
28 Oct 21
Gilead Sciences Announces Third Quarter 2021 Financial Results
4:09pm
8-K
tbwlf9xpt7jpf5heppl
29 Jul 21
Gilead Sciences Announces Second Quarter 2021 Financial Results
4:05pm
8-K
ylqsq1cln1jrnpd4tq
14 May 21
Submission of Matters to a Vote of Security Holders
3:04pm
8-K
jzk8h25lqlkzwot9hh
29 Apr 21
Gilead Sciences Announces First Quarter 2021 Financial Results
4:06pm
8-K
sgpxu7h
4 Feb 21
Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
yk4iif
11 Jan 21
Gilead Sciences Announces Updated 2020 Guidance
6:04am
8-K
9b7nxpb23b7
8 Dec 20
Jeffrey a. Bluestone Joins Gilead Sciences’ Board of Directors
4:14pm
8-K
sdtjh5fca3rjavq
28 Oct 20
Gilead Sciences Announces Third Quarter 2020 Financial Results
4:09pm
8-K
csj4ly79
23 Oct 20
Completion of Acquisition or Disposition of Assets
5:12pm
8-K
rgzutl0w6hqsdm2n6ana
22 Oct 20
Anthony Welters Joins Gilead Sciences’ Board of Directors
12:34pm
8-K
4meas7nvyp yr0r
30 Sep 20
Entry into a Material Definitive Agreement
8:19am
8-K
i1yjw7ia d9vb
29 Sep 20
Entry into a Material Definitive Agreement
4:21pm
8-K
9b6vk3mdw4yuf7s
14 Sep 20
Gilead Sciences to Acquire Immunomedics
8:01am
8-K
gc4u0ey9 ihn
30 Jul 20
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
6:57pm